Kopran Limited (BOM:524280)
India · Delayed Price · Currency is INR 232.70
+0.65 (0.28%)
At close: Sep 4, 2026
Kopran Market Cap
Kopran has a market cap or net worth of 11.24 billion as of September 4, 2026. Its market cap has increased by 34.39% in one year.
Market Cap
11.24B
Enterprise Value
12.76B
Revenue
7.00B
Ranking
n/a
PE Ratio
44.98
Stock Price
232.70
ChartMarket Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 11.24B, an increase of 1,864.35%. That is a compound annual growth rate of 12.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 11.24B | 55.24% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 19.33B |
| TTK Healthcare | 15.55B |
| Amrutanjan Health Care | 14.64B |
| Fermenta Biotech | 14.29B |
| Lincoln Pharmaceuticals | 12.39B |
| Bharat Parenterals | 10.53B |
| Sudarshan Pharma Industries | 9.49B |
| Wanbury | 8.60B |